CARsgen Therapeutics Holdings Limited (2171.HK)

HKD 15.28

(-2.68%)

Revenue Summary of CARsgen Therapeutics Holdings Limited

  • CARsgen Therapeutics Holdings Limited's latest annual revenue in 2023 was - CNY , down 0.0% from previous year.
  • CARsgen Therapeutics Holdings Limited's latest quarterly revenue in 2024 Q2 was - CNY , down 0.0% from previous quarter.
  • CARsgen Therapeutics Holdings Limited reported a annual revenue of - CNY in annual revenue 2022, down -100.0% from previous year.
  • CARsgen Therapeutics Holdings Limited reported a annual revenue of 25.81 Million CNY in annual revenue 2021, down 0.0% from previous year.
  • CARsgen Therapeutics Holdings Limited reported a quarterly revenue of - CNY for 2024 Q1, down 0.0% from previous quarter.
  • CARsgen Therapeutics Holdings Limited reported a quarterly revenue of - CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of CARsgen Therapeutics Holdings Limited (2023 - 2019)

Historical Annual Revenue of CARsgen Therapeutics Holdings Limited (2023 - 2019)

Year Revenue Revenue Growth
2023 - CNY 0.0%
2022 - CNY -100.0%
2021 25.81 Million CNY 0.0%
2020 - CNY 0.0%
2019 - CNY 0.0%

Peer Revenue Comparison of CARsgen Therapeutics Holdings Limited

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 100.0%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 100.0%